CB Insights has named MedRhythms, a digital therapeutics company building direct stimulation solutions that use clinical-grade sensors, software and music to help restore function lost to neurologic disease or injury, to its third annual Digital Health 150, which showcases the 150 most promising private digital health companies in the world.

This year’s Digital Health 150 was unveiled live during CB Insights’ annual Future of Health event.

MedRhythms’ patented digital therapeutics platform uses music to directly target the human motor system to improve walking following neurologic disease and injury. Sensors connect to the shoe and collect clinical-grade data about the patient walking in real time, and the company’s proprietary algorithms build customized interventions to improve users’ speed and quality of walking.

The 2021 Digital Health 150 cohort has raised roughly $14.9B in aggregate funding across 522 deals since 2016 and includes startups at various investment stages of development, from early-stage to well-funded unicorns. Companies this year include startups working on data integration & analytics, hybrid virtual / in-person care, digital therapeutics, clinical intelligence, and more.

“This year’s Digital Health 150 is one of our most expansive yet, spotlighting 16 categories including virtual care, clinical trials tech, and workflow automation, as well as adding new categories such as home health tech and computer-aided imaging.

“Last year’s class has seen more than 20 exits, raised an additional $18.6B in aggregate funding, and announced over 250 partnerships since being recognized, and we’re excited to see the future success of this year’s winners.”

— Brian Lee, SVP of CB Insights’ Intelligence Unit

“We’re thrilled that CB Insights has recognized our accomplishments this year, including our partnership with Universal Music Group, $27M Series B financing, and continued growth of our team. The growth and momentum we’ve seen this year speaks to the need for next-generation digital therapeutics for patients to help improve walking in those living with neurologic injury and disease. We are honored to be named to the CB Insights Digital Health 150 ranking. This recognition is a testament to our team’s tireless work and commitment to improving the lives of the patients we serve.”

— Brian Harris, CEO & Founder, MedRhythms

Through an evidence-based approach, the CB Insights research team selected the Digital Health 150 from a pool of over 11,000 companies, including applicants and nominees. They were chosen based on several factors, including data submitted by the companies, company business models and momentum in the market, and Mosaic scores, CB Insights’ proprietary algorithm that measures the overall health and growth potential of private companies.

[Source(s): MedRhythms, Business Wire]